Literature DB >> 12408055

The chronic graft-versus-host model of systemic autoimmunity.

Robert Eisenberg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12408055     DOI: 10.1159/000066864

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


× No keyword cloud information.
  18 in total

1.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

Review 2.  Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE.

Authors:  I Puliaeva; R Puliaev; C S Via
Journal:  Autoimmun Rev       Date:  2008-08-24       Impact factor: 9.754

3.  Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization.

Authors:  Yanchuan Li; Jin-Young Yang; Xiaoping Xie; Zuliang Jie; Lingyun Zhang; Jianhong Shi; Daniel Lin; Meidi Gu; Xiaofei Zhou; Haiyan S Li; Stephanie S Watowich; Antrix Jain; Sung Yun Jung; Jun Qin; Xuhong Cheng; Shao-Cong Sun
Journal:  Cell Res       Date:  2019-05-13       Impact factor: 25.617

Review 4.  Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens.

Authors:  Charles S Via
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 5.  Advances in lupus stemming from the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Trends Immunol       Date:  2010-03-31       Impact factor: 16.687

6.  Stat1 Regulates Lupus-like Chronic Graft-versus-Host Disease Severity via Interactions with Stat3.

Authors:  Wen-Hai Shao; Ana M Gamero; Yuxuan Zhen; Monica J Lobue; Stephen O Priest; Hazem J Albandar; Philip L Cohen
Journal:  J Immunol       Date:  2015-09-21       Impact factor: 5.422

7.  Pre-clinical screening of immunomodulatory compounds using the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Clin Immunol       Date:  2011-06-12       Impact factor: 3.969

Review 8.  B cell receptor editing in tolerance and autoimmunity.

Authors:  Eline T Luning Prak; Marc Monestier; Robert A Eisenberg
Journal:  Ann N Y Acad Sci       Date:  2011-01-05       Impact factor: 5.691

9.  Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.

Authors:  Charles S Via; Gene M Shearer
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

10.  CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.

Authors:  Roman Puliaev; Irina Puliaeva; Lisbeth A Welniak; Abigail E Ryan; Mark Haas; William J Murphy; Charles S Via
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.